1.Mechanistic Study of Demethylzeylasteral in Alleviating Ulcerative Colitis and Collagen-Induced Arthritis by Regulating Th17 Cell Differentiation
Peiyin YANG ; Le SHI ; Dahai DOU ; Jianxin SHI ; Tao LIANG ; Dongping YUAN ; Yun YU
Journal of Nanjing University of Traditional Chinese Medicine 2025;41(10):1288-1299
OBJECTIVE To investigate the anti-inflammatory mechanisms of demethylzeylasteral(Dem)in ulcerative colitis(UC)and collagen-induced arthritis(CIA),focusing on its regulation of Th17 cell differentiation and associated signaling pathways.METHODS UC was induced in C57BL/6 mice using dextran sulfate sodium(DSS),and Dem was administered by gavage at low(1 mg·kg-1)or high(2 mg·kg-1)doses.Disease severity was assessed by body weight loss,colon length,and stool consisten-cy.Serum cytokines(TNF-α,IL-1β,IL-6)were quantified by ELISA,and Th17 cell ratio in mesenteric lymph nodes was deter-mined by flow cytometry.The anti-inflammatory efficacy of Dem was further validated using a CIA mouse model.The efficacy of Dem was further verified in the CIA model,and the expression of JAK2 and STAT3 was intervened by siRNA to investigate its mechanism of action in Th17 differentiation.RESULTS Dem-treated mice showed reduced weight loss and colon shortening,and decreases in ser-um TNF-α,IL-1β,and IL-6 levels(P<0.01)and Th17 cell proportion(P<0.01).Western blot and siRNA assays showed that Dem significantly inhibited the differentiation and activation of Th17 cells by suppressing the phosphorylation of the JAK2-STAT3 path-way.Dem also significantly alleviated arthritis symptoms and related markers in the CIA model,confirming its anti-inflammatory effects.CONCLUSION Dem improves UC and rheumatoid arthritis by downregulating the JAK2-STAT3 signaling pathway,inhibi-ting Th17 cell differentiation and pro-inflammatory cytokine expression,suggesting its potential therapeutic value in immune-related diseases.
2.Mechanistic Study of Demethylzeylasteral in Alleviating Ulcerative Colitis and Collagen-Induced Arthritis by Regulating Th17 Cell Differentiation
Peiyin YANG ; Le SHI ; Dahai DOU ; Jianxin SHI ; Tao LIANG ; Dongping YUAN ; Yun YU
Journal of Nanjing University of Traditional Chinese Medicine 2025;41(10):1288-1299
OBJECTIVE To investigate the anti-inflammatory mechanisms of demethylzeylasteral(Dem)in ulcerative colitis(UC)and collagen-induced arthritis(CIA),focusing on its regulation of Th17 cell differentiation and associated signaling pathways.METHODS UC was induced in C57BL/6 mice using dextran sulfate sodium(DSS),and Dem was administered by gavage at low(1 mg·kg-1)or high(2 mg·kg-1)doses.Disease severity was assessed by body weight loss,colon length,and stool consisten-cy.Serum cytokines(TNF-α,IL-1β,IL-6)were quantified by ELISA,and Th17 cell ratio in mesenteric lymph nodes was deter-mined by flow cytometry.The anti-inflammatory efficacy of Dem was further validated using a CIA mouse model.The efficacy of Dem was further verified in the CIA model,and the expression of JAK2 and STAT3 was intervened by siRNA to investigate its mechanism of action in Th17 differentiation.RESULTS Dem-treated mice showed reduced weight loss and colon shortening,and decreases in ser-um TNF-α,IL-1β,and IL-6 levels(P<0.01)and Th17 cell proportion(P<0.01).Western blot and siRNA assays showed that Dem significantly inhibited the differentiation and activation of Th17 cells by suppressing the phosphorylation of the JAK2-STAT3 path-way.Dem also significantly alleviated arthritis symptoms and related markers in the CIA model,confirming its anti-inflammatory effects.CONCLUSION Dem improves UC and rheumatoid arthritis by downregulating the JAK2-STAT3 signaling pathway,inhibi-ting Th17 cell differentiation and pro-inflammatory cytokine expression,suggesting its potential therapeutic value in immune-related diseases.
3.The Treatment Idea for Postoperative "Eliminating Abdominal Mass to Help Pregnancy" in Lingnan LUO's Gynaecology
Xijing LU ; Songping LUO ; Peiyin LI ; Zitong LIN ; Zheyanxuan YANG ; Lei ZENG
Journal of Traditional Chinese Medicine 2024;65(21):2205-2210
Based on the characteristics of postoperative gynaecological diseases, Lingnan LUO's Gynaecology has summarized the idea of "eliminating abdominal mass to help pregnancy", and applied the elimination method in the postoperative gynaecological treatment to promote rehabilitation, prevent recurrence, and regulate menstruation in a sequential manner, which is divided into three phases of diagnosis and treatment. The first stage of postoperative rehabilitation (2 weeks after surgery) is based on the pathogenesis of profuse deficiency, profuse stasis, and easy to retain pathogens, and the treatment should focus on tonifying the positive qi and eliminating abdominal mass at the same time, commonly used in modified Sijunzi Dcoction (四君子汤) and Shenghua Dcoction (生化汤). In the second stage of postoperative rehabilitation (2 weeks to 2-3 months after surgery), the pathogenesis is mainly kidney deficiency and blood stasis, which should be treated by tonifying kidney and supplement essence, eliminate blood stasis and eliminate abdominal mass, and commonly use the Guishen Pill (归肾丸) with herbs that invigorating blood, dissolving stasis, and clearing the collaterals. Postoperative sequential menstrual regulation and fertility promotion stage (after the end of the postoperative rehabilitation stage, the normal anatomy of the uterine cavity and pelvis is basically restored) adopts cyclic sequential therapy, according to the characteristics of the pathogenesis of the different periods of menstruation in phases, always tonifying kidney and regulating menstruation, eliminating abdominal mass, and attaches importance to the application of four methods of eliminating abdominal mass, including invigorating blood and dissolving stasis, moving qi to resolve constraint, dissolving phlegm and dispelling dampness, resolving accumulation and removing stagnation.

Result Analysis
Print
Save
E-mail